Extensive functional evaluation of exon 20 insertion mutations of EGFR
Author:
Funder
AstraZeneca
Japan Agency for Medical Research and Development
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference48 articles.
1. EGF-ERBB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell Biol.,2006
2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004
3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004
4. EGFR antagonists in cancer treatment;Ciardiello;N. Engl. J. Med.,2008
5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N. Engl. J. Med.,2010
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy;Acta Oncologica;2023-11-08
2. Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene;Cancer Science;2023-08-17
3. Rare case of de novo EGFR L718V mutation-positive non-small cell lung cancer successfully treated with afatinib;Current Problems in Cancer: Case Reports;2023-06
4. Targeted therapy;Medicines for Cancer;2023
5. Targeting exon 20 insertion mutations in lung cancer;Current Opinion in Oncology;2022-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3